104030-31-1,MFCD00238786
Catalog No.:AA01EM1J

104030-31-1 | (2E)-2-(1H-1,3-benzodiazol-2-yl)-3-(thiophen-2-yl)prop-2-enenitrile

Pack Size
Purity
Availability
Price(USD)
Quantity
  
50mg
95%
3 weeks  
$145.00   $102.00
- +
100mg
95%
3 weeks  
$186.00   $130.00
- +
250mg
95%
3 weeks  
$243.00   $170.00
- +
500mg
95%
3 weeks  
$350.00   $245.00
- +
1g
95%
3 weeks  
$433.00   $303.00
- +
2.5g
95%
3 weeks  
$792.00   $554.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA01EM1J
Chemical Name:
(2E)-2-(1H-1,3-benzodiazol-2-yl)-3-(thiophen-2-yl)prop-2-enenitrile
CAS Number:
104030-31-1
Molecular Formula:
C14H9N3S
Molecular Weight:
251.3064
MDL Number:
MFCD00238786
SMILES:
N#C/C(=C\c1cccs1)/c1nc2c([nH]1)cccc2
Properties
Computed Properties
 
Complexity:
384  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
1  
Formal Charge:
0  
Heavy Atom Count:
18  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
2  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
3  

Literature

Title: Time-dependent botulinum neurotoxin serotype A metalloprotease inhibitors.

Journal: Bioorganic & medicinal chemistry 20111215

Title: Benzimidazole derivatives related to 2,3-acrylonitriles, benzimidazo[1,2-a]quinolines and fluorenes: synthesis, antitumor evaluation in vitro and crystal structure determination.

Journal: European journal of medicinal chemistry 20100601

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Title: Synthesis, X-ray crystal structures, stabilities, and in vitro cytotoxic activities of new heteroarylacrylonitriles.

Journal: Journal of medicinal chemistry 20040617

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 104030-31-1
Tags:104030-31-1 Molecular Formula|104030-31-1 MDL|104030-31-1 SMILES|104030-31-1 (2E)-2-(1H-1,3-benzodiazol-2-yl)-3-(thiophen-2-yl)prop-2-enenitrile
Catalog No.: AA01EM1J
104030-31-1,MFCD00238786
104030-31-1 | (2E)-2-(1H-1,3-benzodiazol-2-yl)-3-(thiophen-2-yl)prop-2-enenitrile
Pack Size: 50mg
Purity: 95%
3 weeks
$145.00 $102.00
Pack Size: 100mg
Purity: 95%
3 weeks
$186.00 $130.00
Pack Size: 250mg
Purity: 95%
3 weeks
$243.00 $170.00
Pack Size: 500mg
Purity: 95%
3 weeks
$350.00 $245.00
Pack Size: 1g
Purity: 95%
3 weeks
$433.00 $303.00
Pack Size: 2.5g
Purity: 95%
3 weeks
$792.00 $554.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA01EM1J
Chemical Name: (2E)-2-(1H-1,3-benzodiazol-2-yl)-3-(thiophen-2-yl)prop-2-enenitrile
CAS Number: 104030-31-1
Molecular Formula: C14H9N3S
Molecular Weight: 251.3064
MDL Number: MFCD00238786
SMILES: N#C/C(=C\c1cccs1)/c1nc2c([nH]1)cccc2
Properties
Complexity: 384  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 1  
Formal Charge: 0  
Heavy Atom Count: 18  
Hydrogen Bond Acceptor Count: 3  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 2  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 3  
Literature fold

Title: Time-dependent botulinum neurotoxin serotype A metalloprotease inhibitors.

Journal: Bioorganic & medicinal chemistry20111215

Title: Benzimidazole derivatives related to 2,3-acrylonitriles, benzimidazo[1,2-a]quinolines and fluorenes: synthesis, antitumor evaluation in vitro and crystal structure determination.

Journal: European journal of medicinal chemistry20100601

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology20060501

Title: Synthesis, X-ray crystal structures, stabilities, and in vitro cytotoxic activities of new heteroarylacrylonitriles.

Journal: Journal of medicinal chemistry20040617

Building Blocks More >
1895732-44-1
1895732-44-1
2-(oxan-4-yl)prop-2-enenitrile
AA01EM5H | MFCD31559722
2126161-54-2
2126161-54-2
4-iodo-2,5-dimethylbenzaldehyde
AA01EM9C | MFCD31381396
3587-84-6
3587-84-6
2-methoxy-1-phenylethan-1-ol
AA01EMCQ | MFCD14691054
1545764-84-8
1545764-84-8
2-[3-(Aminomethyl)benzenesulfonyl]ethan-1-ol
AA01EMGB | MFCD24247758
2138549-03-6
2138549-03-6
3-bromo-5,6,7,8-tetrahydro-1,6-naphthyridin-4-ol hydrochloride
AA01EMJL | MFCD31559200
39974-01-1
39974-01-1
ethyl 4-(4-hydroxyphenyl)-2,4-dioxobutanoate
AA01EMMW | MFCD31666504
1780526-08-0
1780526-08-0
[1-(1,1-difluoroethyl)cyclopropyl]methanol
AA01EMQF | MFCD28550004
118786-13-3
118786-13-3
tert-butyl (1s,4s)-4-aminocyclohexane-1-carboxylate hydrochloride, cis
AA01EMV6 | MFCD31629459
340774-69-8
340774-69-8
(2E)-4-[(1R,5R,6R)-3-(1E)-1-Hepten-1-yl-5-hydroxy-4-(hydroxymethyl)-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-1-yl]-2-methyl-2-butenoicacid
AA01ENEO | MFCD28898930
201422-04-0
201422-04-0
L-Leucine,N2-(1-oxotetradecyl)-L-lysyl-L-lysyl-L-alanyl-L-leucyl-L-arginyl-L-arginyl-L-glutaminyl-L-a-glutamyl-L-alanyl-L-valyl-L-a-aspartyl-L-alanyl-
AA01ENHU | MFCD01076524
Submit
© 2017 AA BLOCKS, INC. All rights reserved.